Updates and Trends China expedites the price reduction of anticancer drugs – the third round of national drug price negotiation is about to start

China expedites the price reduction of anticancer drugs – the third round of national drug price negotiation is about to start

In the recent years, the medical reform has taken the center stage in China and a great amount of efforts has poured in. In an attempt to reduce the high drug price and improve its medical insurance coverage, China has initiated a series of new moves, including the most recent zero import tax on a …

Read Article Read More

Updates and Trends China’s Removal of Imported Drug Tariffs

China’s Removal of Imported Drug Tariffs

In the face of high tariffs, multiple layers of distribution, and monopoly supply, imported drugs have been extremely expensive in China. And this issue especially affects imported anticancer medications, which, compared with their counterparts abroad, are normally priced 2–3 times, sometimes even five times higher in China. An increasing number of Chinese patients are forced …

Read Article Read More